0001209191-14-049691.txt : 20140731 0001209191-14-049691.hdr.sgml : 20140731 20140731123025 ACCESSION NUMBER: 0001209191-14-049691 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140731 FILED AS OF DATE: 20140731 DATE AS OF CHANGE: 20140731 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aegerion Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001338042 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202960116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 MAIN STREET STREET 2: SUITE 1850 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (617) 500-7867 MAIL ADDRESS: STREET 1: 101 MAIN STREET STREET 2: SUITE 1850 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Aegerion Pharmaceuticals Inc DATE OF NAME CHANGE: 20050906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Beer Marc D CENTRAL INDEX KEY: 0001314575 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34921 FILM NUMBER: 141005457 MAIL ADDRESS: STREET 1: C/O AEGERION PHARMACEUTICALS STREET 2: 89 HEADQUARTERS PLAZA, SUITE 1212 CITY: MORRISTOWN STATE: NJ ZIP: 07960 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-07-31 0 0001338042 Aegerion Pharmaceuticals, Inc. AEGR 0001314575 Beer Marc D C/O AEGERION PHARMACEUTICALS, INC. 101 MAIN STREET, SUITE 1850 CAMBRIDGE MA 02142 1 1 0 0 Chief Executive Officer Common Stock 2014-07-31 4 P 0 7700 33.44 A 77100 D Common Stock 2014-07-31 4 P 0 2300 34.37 A 79400 D Common Stock 183245 I By revocable trust Common Stock 55861 I By grantor retained annuity trust Common Stock 7156 I By Roth IRA Common Stock 200 I By son The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $33.02 to $33.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $34.02 to $34.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. /s/ Anne Marie Cook, attorney-in-fact 2014-07-31